CA2992662A1 - Phenyl urea analogs as formyl peptide repceptor 1 (fpr1) selective agonists - Google Patents
Phenyl urea analogs as formyl peptide repceptor 1 (fpr1) selective agonists Download PDFInfo
- Publication number
- CA2992662A1 CA2992662A1 CA2992662A CA2992662A CA2992662A1 CA 2992662 A1 CA2992662 A1 CA 2992662A1 CA 2992662 A CA2992662 A CA 2992662A CA 2992662 A CA2992662 A CA 2992662A CA 2992662 A1 CA2992662 A1 CA 2992662A1
- Authority
- CA
- Canada
- Prior art keywords
- optionally substituted
- alkyl
- disease
- retinal
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562201387P | 2015-08-05 | 2015-08-05 | |
| US62/201,387 | 2015-08-05 | ||
| PCT/US2016/045114 WO2017023907A1 (en) | 2015-08-05 | 2016-08-02 | Phenyl urea analogs as formyl peptide repceptor 1 (fpr1) selective agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2992662A1 true CA2992662A1 (en) | 2017-02-09 |
Family
ID=56684759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2992662A Abandoned CA2992662A1 (en) | 2015-08-05 | 2016-08-02 | Phenyl urea analogs as formyl peptide repceptor 1 (fpr1) selective agonists |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200079729A1 (https=) |
| EP (1) | EP3331897B1 (https=) |
| JP (2) | JP6900365B2 (https=) |
| AU (2) | AU2016302146B2 (https=) |
| CA (1) | CA2992662A1 (https=) |
| TW (1) | TW201718473A (https=) |
| WO (1) | WO2017023907A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12478503B2 (en) | 2009-05-18 | 2025-11-25 | Glaukos Corporation | Implants with controlled drug delivery features and methods of using same |
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| TW201718473A (zh) * | 2015-08-05 | 2017-06-01 | 歐樂根公司 | 作為甲醯肽受體1(fpr1)選擇性促效劑之苯基脲類似物 |
| ITUB20169937A1 (it) * | 2016-01-12 | 2017-07-12 | Medical And Biotechnological Services In Sigla M B S Srl | Formulazioni farmaceutiche e loro uso per il trattamento della retinite pigmentosa |
| CN109715602A (zh) | 2016-03-28 | 2019-05-03 | 阿勒根公司 | 苯基脲衍生物作为n-甲酰肽受体调节剂 |
| EP3442950A1 (en) | 2016-04-12 | 2019-02-20 | Allergan, Inc. | Phenyl urea derivatives as n-formyl peptide receptor modulators |
| EP3856228B1 (en) * | 2018-09-27 | 2023-03-08 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Tafa4 polypeptide for use for reducing skin inflammation |
| GB202404002D0 (en) * | 2024-03-20 | 2024-05-01 | Univ Bristol | Antimicrobial compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3387948B2 (ja) * | 1992-12-04 | 2003-03-17 | 富山化学工業株式会社 | 新規なフェニルアラニン誘導体またはその塩 |
| AU2012329098B2 (en) * | 2011-10-26 | 2017-08-03 | Allergan, Inc. | Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
| ES2711363T3 (es) * | 2012-04-16 | 2019-05-03 | Allergan Inc | Derivados de (2-ureidoacetamido)alquilo como moduladores del receptor 2 de péptidos formilados |
| RU2696581C2 (ru) * | 2013-07-16 | 2019-08-05 | Аллерган, Инк. | Производные n-мочевинозамещенных аминокислот как модуляторы формил-пептидного рецептора |
| TW201718473A (zh) * | 2015-08-05 | 2017-06-01 | 歐樂根公司 | 作為甲醯肽受體1(fpr1)選擇性促效劑之苯基脲類似物 |
-
2016
- 2016-08-02 TW TW105124494A patent/TW201718473A/zh unknown
- 2016-08-02 US US15/746,918 patent/US20200079729A1/en not_active Abandoned
- 2016-08-02 CA CA2992662A patent/CA2992662A1/en not_active Abandoned
- 2016-08-02 WO PCT/US2016/045114 patent/WO2017023907A1/en not_active Ceased
- 2016-08-02 AU AU2016302146A patent/AU2016302146B2/en not_active Ceased
- 2016-08-02 EP EP16751427.2A patent/EP3331897B1/en not_active Not-in-force
- 2016-08-02 JP JP2018505625A patent/JP6900365B2/ja not_active Expired - Fee Related
-
2020
- 2020-12-24 AU AU2020294291A patent/AU2020294291A1/en not_active Abandoned
-
2021
- 2021-06-16 JP JP2021100178A patent/JP2021178821A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2016302146A1 (en) | 2018-02-08 |
| JP2018532692A (ja) | 2018-11-08 |
| EP3331897B1 (en) | 2021-03-24 |
| WO2017023907A1 (en) | 2017-02-09 |
| AU2016302146B2 (en) | 2021-01-28 |
| JP2021178821A (ja) | 2021-11-18 |
| TW201718473A (zh) | 2017-06-01 |
| AU2020294291A1 (en) | 2021-01-28 |
| EP3331897A1 (en) | 2018-06-13 |
| US20200079729A1 (en) | 2020-03-12 |
| JP6900365B2 (ja) | 2021-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3331897B1 (en) | Phenyl urea analogs as formyl peptide receptor 1 (fpr1) selective agonists | |
| CA2917811C (en) | Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators | |
| WO2013158597A1 (en) | (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators | |
| EP3145916B1 (en) | Imidazole derivatives as formyl peptide receptor modulators | |
| AU2014352922A1 (en) | Phenylcarbamate derivatives as formyl peptide receptor modulators | |
| WO2015042071A1 (en) | Diphenyl urea derivatives as formyl peptide receptor modulators | |
| AU2021261917A1 (en) | Phenyl urea derivatives as N-formyl peptide receptor modulators | |
| US11117860B2 (en) | Phenyl urea derivatives as n-formyl peptide receptor modulators | |
| WO2015116574A1 (en) | Urea hydantoin derivatives as formyl peptide modulators | |
| US20240025844A1 (en) | Phenyl urea analogs as formyl peptide receptor 1 (fpr1) selective agonists | |
| HK1225012A1 (en) | Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210719 |
|
| FZDE | Discontinued |
Effective date: 20240123 |